Kolosis BIO Announces 2021 Results

Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.

Kolosis BIO Announces Release of Scientific White Paper

Salt Lake City, Utah – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the completion and release of a scientific white paper studying the effects of terminal sterilization on allograft tissues.